BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 Feb 2024
15 Feb 2024
Historique:
received:
07
11
2023
accepted:
07
02
2024
medline:
16
2
2024
pubmed:
16
2
2024
entrez:
15
2
2024
Statut:
epublish
Résumé
Though new targeted therapies for colorectal cancer, which progresses from local intestinal tumors to metastatic disease, are being developed, tumor specificity remains an important problem, and side effects a major concern. Here, we show that the protein-fatty acid complex BAMLET (bovine alpha-lactalbumin made lethal to tumor cells) can act as a peroral treatment for colorectal cancer. Apc
Identifiants
pubmed: 38360830
doi: 10.1038/s41598-024-54040-w
pii: 10.1038/s41598-024-54040-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3838Subventions
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Organisme : Horizon 2020 Framework Programme
ID : 954360
Informations de copyright
© 2024. The Author(s).
Références
Abbas, Z. & Rehman, S. An overview of cancer treatment modalities. Neoplasm 1, 139–157 (2018).
Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).
doi: 10.3322/caac.21660
pubmed: 33538338
Jasperson, K. W., Patel, S. G. & Ahnen, D. J. APC-associated polyposis conditions. GeneReviews®[Internet] (2017).
Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. New Engl. J. Med. 319, 525–532 (1988).
doi: 10.1056/NEJM198809013190901
pubmed: 2841597
McCart, A. E., Vickaryous, N. K. & Silver, A. Apc mice: Models, modifiers and mutants. Pathol.-Res. Pract. 204, 479–490 (2008).
doi: 10.1016/j.prp.2008.03.004
pubmed: 18538487
Moser, A. R., Pitot, H. C. & Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322–324 (1990).
doi: 10.1126/science.2296722
pubmed: 2296722
The Jackson Laboratory. C57BL/6J-ApcMin/J. https://www.jax.org/strain/002020 (2023).
Mok, K. H., Nagashima, T., Day, I. J., Hore, P. & Dobson, C. M. Multiple subsets of side-chain packing in partially folded states of α-lactalbumins. Proc. Natl. Acad. Sci. 102, 8899–8904 (2005).
doi: 10.1073/pnas.0500661102
pubmed: 15956205
pmcid: 1157025
Pettersson, J., Mossberg, A.-K. & Svanborg, C. α-Lactalbumin species variation, HAMLET formation, and tumor cell death. Biochem. Biophys. Res. Commun. 345, 260–270 (2006).
doi: 10.1016/j.bbrc.2006.04.081
pubmed: 16678133
Rammer, P. et al. BAMLET activates a lysosomal cell death program in cancer cells. Mol Cancer Therap. 9, 24–32. https://doi.org/10.1158/1535-7163.Mct-09-0559 (2010).
doi: 10.1158/1535-7163.Mct-09-0559
Brinkmann, C. R., Heegaard, C. W., Petersen, T. E., Jensenius, J. C. & Thiel, S. The toxicity of bovine α-lactalbumin made lethal to tumor cells is highly dependent on oleic acid and induces killing in cancer cell lines and noncancer-derived primary cells. FEBS J. 278, 1955–1967 (2011).
doi: 10.1111/j.1742-4658.2011.08112.x
pubmed: 21457462
Zhong, S. et al. Cytotoxicity and apoptosis induction of bovine alpha-lactalbumin-oleic acid complex in human breast cancer cells. Food Sci. Technol. Res. 21, 103–110 (2015).
doi: 10.3136/fstr.21.103
Mahanta, S. & Paul, S. Stable self-assembly of bovine α-lactalbumin exhibits target-specific antiproliferative activity in multiple cancer cells. ACS Appl. Mater. Interfaces 7, 28177–28187 (2015).
doi: 10.1021/acsami.5b06076
pubmed: 26440360
Sinevici, N. et al. The novel therapeutic potential of bovine α-lactalbumin made lethal to tumour cells (BALMET) and oleic acid in oral squamous cell carcinoma (OSCC). Eur. J. Cancer Prev. 30, 178–187 (2021).
doi: 10.1097/CEJ.0000000000000617
pubmed: 32694279
HåkanssoN, A., Zhivotovsky, B., Orrenius, S., Sabrarwal, H. & Svanborg, C. Apoptosis induced by a human milk protein. Proc. Natl. Acad. Sci. 92, 8064–8068 (1995).
doi: 10.1073/pnas.92.17.8064
pubmed: 7644538
pmcid: 41287
Pettersson-Kastberg, J. et al. α-Lactalbumin, engineered to be nonnative and inactive, kills tumor cells when in complex with oleic acid: A new biological function resulting from partial unfolding. J. Mol. Biol. 394, 994–1010 (2009).
doi: 10.1016/j.jmb.2009.09.026
pubmed: 19766653
Svensson, M., Håkansson, A., Mossberg, A.-K., Linse, S. & Svanborg, C. Conversion of α-lactalbumin to a protein inducing apoptosis. Proc. Natl. Acad. Sci. 97, 4221–4226. https://doi.org/10.1073/pnas.97.8.4221 (2000).
doi: 10.1073/pnas.97.8.4221
pubmed: 10760289
pmcid: 18203
Duringer, C., Hamiche, A., Gustafsson, L., Kimura, H. & Svanborg, C. HAMLET interacts with histones and chromatin in tumor cell nuclei. J. Biol. Chem. 278, 42131–42135 (2003).
doi: 10.1074/jbc.M306462200
pubmed: 12888554
Svensson, M. et al. α-Lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human α-lactalbumin made lethal to tumor cells). Prot. Sci. 12, 2794–2804. https://doi.org/10.1110/ps.0231003 (2003).
doi: 10.1110/ps.0231003
Gustafsson, L., Leijonhufvud, I., Aronsson, A., Mossberg, A.-K. & Svanborg, C. Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid. New Engl. J. Med. 350, 2663–2672. https://doi.org/10.1056/NEJMoa032454 (2004).
doi: 10.1056/NEJMoa032454
pubmed: 15215482
Fischer, W. et al. Human α-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res. 64, 2105–2112 (2004).
doi: 10.1158/0008-5472.CAN-03-2661
pubmed: 15026350
Mossberg, A. K. et al. Bladder cancers respond to intravesical instillation of (HAMLET human α-lactalbumin made lethal to tumor cells). Int. J. Cancer 121, 1352–1359 (2007).
doi: 10.1002/ijc.22810
pubmed: 17514650
Mossberg, A.-K., Hou, Y., Svensson, M., Holmqvist, B. & Svanborg, C. HAMLET treatment delays bladder cancer development. J. Urol. 183, 1590–1597 (2010).
doi: 10.1016/j.juro.2009.12.008
pubmed: 20172551
Puthia, M., Storm, P., Nadeem, A., Hsiung, S. & Svanborg, C. Prevention and treatment of colon cancer by peroral administration of HAMLET (human α-lactalbumin made lethal to tumour cells). Gut 63, 131–142 (2014).
doi: 10.1136/gutjnl-2012-303715
pubmed: 23348960
Brisuda, A. et al. Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex. Nat. Commun. 12, 1–16 (2021).
doi: 10.1038/s41467-021-23748-y
Su, L.-K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668–670 (1992).
doi: 10.1126/science.1350108
pubmed: 1350108
Stenhouse, G., Fyfe, N., King, G., Chapman, A. & Kerr, K. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J. Clin. Pathol. 57, 383–387 (2004).
doi: 10.1136/jcp.2003.007138
pubmed: 15047742
pmcid: 1770279
Hien, T. T. et al. Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy. Int. J. Cancer 1, 1 (2023).
Hansen, J. S. et al. Peptide–oleate complexescreate novel membrane-bound compartments. Mol. Biol. Evol. 37, 3083–3093 (2020).
doi: 10.1093/molbev/msaa138
pubmed: 32521018
Brest, P. et al. Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. Cancer research 67, 11327–11334 (2007).
doi: 10.1158/0008-5472.CAN-07-1153
pubmed: 18056459
Storm, P. et al. Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis. Oncogene 30, 4765–4779 (2011).
doi: 10.1038/onc.2011.196
pubmed: 21643007
pmcid: 4041205
Halberg, R. B. et al. Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Cancer Res. 69, 5768–5775 (2009).
doi: 10.1158/0008-5472.CAN-09-0446
pubmed: 19584276
pmcid: 2775466
Königshoff, M. et al. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PloS One 3, e2142 (2008).
doi: 10.1371/journal.pone.0002142
pubmed: 18478089
pmcid: 2374879
Wong, R. P., Hwang, W. S. & Field, S. K. Familial adenomatous polyposis and lung cancer. J. Surg. Oncol. 60, 213–214 (1995).
doi: 10.1002/jso.2930600314
pubmed: 7475074
Yamaguchi, M. & Takai, S. Chronic Administration of bovine milk-derived α-lactalbumin improves glucose tolerance via enhancement of adiponectin in goto–kakizaki rats with type 2 diabetes. Biol. Pharm. Bull. 37, 404–408 (2014).
doi: 10.1248/bpb.b13-00762
pubmed: 24583859
Gao, J., Song, J., Du, M. & Mao, X. Bovine α-lactalbumin hydrolysates (α-LAH) ameliorate adipose insulin resistance and inflammation in high-fat diet-fed C57BL/6J mice. Nutrients 10, 242 (2018).
doi: 10.3390/nu10020242
pubmed: 29473848
pmcid: 5852818
Boscaini, S. et al. Dietary α-lactalbumin alters energy balance, gut microbiota composition and intestinal nutrient transporter expression in high-fat diet-fed mice. Br. J. Nutrit. 121, 1097–1107 (2019).
doi: 10.1017/S0007114519000461
Brahmer, J. R. et al. Safety and activity of anti–PD-L1 antibody in patients with advanced cancer. New Engl. J. Med. 366, 2455–2465 (2012).
doi: 10.1056/NEJMoa1200694
pubmed: 22658128
Hu, H. et al. Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial. Lancet Gastroenterol. Hepatol. 7, 38–48 (2022).
doi: 10.1016/S2468-1253(21)00348-4
pubmed: 34688374
Le, D. T. et al. PD-1 blockade in tumors with mismatch-repair deficiency. New Engl. J. Med. 372, 2509–2520. https://doi.org/10.1056/NEJMoa1500596 (2015).
doi: 10.1056/NEJMoa1500596
pubmed: 26028255
Patsoukis, N., Wang, Q., Strauss, L. & Boussiotis, V. A. Revisiting the PD-1 pathway. Sci. Adv. 6, ea2712 (2020).
doi: 10.1126/sciadv.abd2712
Stacey, A. et al. Lactation is disrupted by alpha-lactalbumin deficiency and can be restored by human alpha-lactalbumin gene replacement in mice. Proc. Natl. Acad. Sci. 92, 2835–2839. https://doi.org/10.1073/pnas.92.7.2835 (1995).
doi: 10.1073/pnas.92.7.2835
pubmed: 7708733
pmcid: 42313
Wijesinha-Bettoni, R., Dobson, C. M. & Redfield, C. Comparison of the structural and dynamical properties of holo and apo bovine α-lactalbumin by NMR spectroscopy. J. Mol. Biol. 307, 885–898 (2001).
doi: 10.1006/jmbi.2001.4530
pubmed: 11273708
Krämer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30, 523–530 (2014).
doi: 10.1093/bioinformatics/btt703
pubmed: 24336805